The Influenza Virus Vaccine, cataloged under National Stock Number 6505-01-735-0237, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sanofi Pasteur Inc.. Government technical data includes 2 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-735-0237 |
| Primary Part Number | NDC49281-0126-65 |
| Item Name | Influenza Virus Vaccine |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sanofi Pasteur Inc. |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC49281-0126-65 PRIMARY | Sanofi Pasteur Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1710373 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM252125 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-735-0237 is a Influenza Virus Vaccine, manufactured by Sanofi Pasteur Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-735-0237 has 1 manufacturer part number on file: NDC49281-0126-65 (Sanofi Pasteur Inc.).
Key specifications for NDC49281-0126-65: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Special Features: TRIVALENT PREFILLED SYRINGE; 0.5 ML SINGLE DOSE PREFILLED SYRINGE, PG OF 10 (W/O NEEDLES); INACTIVATED INFLUENZA VACCINE; FOR FLU SEASON 2026-2027; FOR IMMUNIZING PERSONS 65 YEARS OF AGE AND OLDER; LATEX-FREE, PRESERVATIVE FREE; FOR IM ADMINISTRATION; REQUIRES REFRIGERATION BETWEEN 2-8 DEG C; DO NOT FREEEZE DEGC; Protective Storage Feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS; Part Name Assigned by Controlling Agency: INFLUENZA VIRUS VACCINE, USP, FLUZONE HIGH DOSE; 2026-2027 FORMULA. 2 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.